The recommended dose for the Phase 2 study is 300mg, twice daily.
New and more efficient trial design coming up then FDA approval to commence Phase 2.
Let's get all the oppies at 6c to exercise by July to fund Phase 2!
- Forums
- ASX - By Stock
- ILA
- Ann: New data leads to proposed ISLA-101 Phase 2 efficiencies
Ann: New data leads to proposed ISLA-101 Phase 2 efficiencies, page-3
Featured News
Add ILA (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.70M |
Open | High | Low | Value | Volume |
12.0¢ | 13.5¢ | 12.0¢ | $80.72K | 671.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 98882 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 93382 | 0.115 |
6 | 132959 | 0.110 |
3 | 350000 | 0.105 |
4 | 249999 | 0.100 |
1 | 50000 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 80000 | 1 |
0.135 | 13982 | 1 |
0.160 | 25000 | 1 |
0.170 | 129032 | 1 |
0.175 | 25000 | 1 |
Last trade - 15.45pm 08/11/2024 (20 minute delay) ? |
Featured News
ILA (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online